Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MNC Kapital Indonesia Tbk (BCAP) vs Jayamas Medica Industri Tbk. (OMED) Price & Performance

MNC Kapital Indonesia TbkTrade
Jayamas Medica Industri Tbk.Trade

Price performance (Past 24H)

Key statistics

MNC Kapital Indonesia Tbk vs Jayamas Medica Industri Tbk. — how do they compare? MNC Kapital Indonesia Tbk trades at Rp50 (market cap 2.13T, 136K 24h volume), while Jayamas Medica Industri Tbk. trades at Rp202 (market cap 5.52T, 54.86M 24h volume). The key difference: Jayamas Medica Industri Tbk. is far larger — about 2.6× MNC Kapital Indonesia Tbk's market cap, and Jayamas Medica Industri Tbk. is more actively traded (54.86M versus 136K). Which is the better fit depends on your goals.

BCAPOMED
Market Cap
2.13T5.52T
Volume
136K54.86M
Lot
1.36K548.64K
Turnover
6.8M10.89B
Average Price
50198.47
Value
6.8M10.89B
Indicative Equilibrium Price
50202
Indicative Equilibrium Volume
174.94K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BCAP
View details
OMED
View details

About MNC Kapital Indonesia Tbk

PT MNC Kapital Indonesia Tbk formerly PT Bhakti Capital Indonesia Tbk was established on 15 July 1999, resulting from the restructuring and consolidation of PT Bhakti Investama Tbk, its holding company. At the time it was established, the Company commenced its business activities in the securities sector, among others are financial advisory, brokerage, underwriting, and research and development. In 2003, the Company carried out a business consolidation and transformed into a holding company of several subsidiaries that are engaged in financial services sector, namely PT Bhakti Finance, PT Bhakti Securities, and PT Bhakti Asset Management.

Read more on BCAP

About Jayamas Medica Industri Tbk.

PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.

Read more on OMED